Interpretation of serum CK-MB activity measured by immunoinhibition assay requires special care in patients with neoplastic pathology.
Bor
M V
MV
D018288:Carcinoma, Small Cell / Q000150:complications / Q000201:enzymology; D002637:Chest Pain / Q000150:complications / Q000201:enzymology; D003402:Creatine Kinase / Q000097:blood*; D006801:Humans; D007118:Immunoassay / Q000379:methods; D007527:Isoenzymes; D008175:Lung Neoplasms / Q000150:complications / Q000201:enzymology; D009203:Myocardial Infarction / Q000150:complications / Q000175:diagnosis / Q000201:enzymology*; D009369:Neoplasms / Q000150:complications / Q000201:enzymology*
D007527:Isoenzymes; D003402:Creatine Kinase